Bioptimus vs Superluminal Medicines
Which Drug Discovery AI tool is better in 2026?
Bioptimus
Building the first universal AI foundation model for biology.
Superluminal Medicines
AI biotech company developing small-molecule drugs that target G protein-coupled receptors
Side-by-side
Superluminal Medicines is the more established option (raised $120M); pricing is comparable on both sides.
| Metric | Bioptimus | Superluminal Medicines |
|---|---|---|
| Taglinei | Building the first universal AI foundation model for biology. | AI biotech company developing small-molecule drugs that target G protein-coupled receptors |
| Foundedi | 2024 | 2023🏆 |
| HQi | Paris, FR | — |
| Employeesi | 11-50 | 11-50🏆 |
| Neuron scorei | 59🏆 | 51 |
| Total fundingi | $76M | $120M🏆 |
| Latest roundi | Series A · Jan 2025 | Series A |
| Valuationi | — | — |
| Cheapest paid plani | Pricing not disclosed | Pricing not disclosed |
| Free plani | ✗ | ✓ |
| Free triali | ✗ | ✓ |
| Top tier pricei | Pricing not disclosed | Pricing not disclosed |
| Pricing summaryi | Enterprise · Contact sales | Free |
| Categoriesi |
Capability matrix
Developer-facing capabilities and access signals for Bioptimus and Superluminal Medicines.
| Capability | Bioptimus | Superluminal Medicines |
|---|---|---|
| MCP support | ✗ | ✗ |
| Public API | ✗ | ✗ |
| Webhooks | ✗ | ✗ |
| OAuth 2.0 | ✗ | ✗ |
| SDK languages | — | — |
| Free plan | ✗ | ✓ |
| Free trial | ✗ | ✓ |
| Verified | ✗ | ✗ |
| Active deal | ✗ | ✗ |
🟢 Strengths of Bioptimus
- Higher Neuron score (59 vs 51)
- Newer company (2024)
🔵 Strengths of Superluminal Medicines
- Has raised more capital ($120M vs $76M)
- Offers a free plan
- Offers a free trial
- More mature (2023)
Which should you choose?
Choose Superluminal Medicines if price matters most — it starts at Free, which is friendlier for teams watching burn. Both Drug Discovery tools ship core features, so the cost delta often decides it for small teams and solo operators.
Choose Superluminal Medicines if you want the most established option — it has raised $120M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.
Frequently asked questions
Bioptimus vs Superluminal Medicines — which is better?
It depends on your priority. Bioptimus is the leaner option; Superluminal Medicines has broader feature depth. See the side-by-side table above.
Is Bioptimus cheaper than Superluminal Medicines?
No — Superluminal Medicines's cheapest paid plan is Free, while Bioptimus's is Enterprise · Contact sales.
Do Bioptimus and Superluminal Medicines offer free plans?
Bioptimus: Paid only. Superluminal Medicines: Yes, has a free plan.
Explore more Drug Discovery tools
Contextual paths to related AI startups, deals and rankings.